Alimera Sciences, Inc.
ALIM · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $110 | $19 | $34 | $22 |
| - Cash | $12 | $5 | $17 | $11 |
| + Debt | $67 | $44 | $44 | $45 |
| Enterprise Value | $166 | $58 | $61 | $55 |
| Revenue | $81 | $54 | $59 | $51 |
| % Growth | 49.2% | -8.3% | 16.2% | – |
| Gross Profit | $61 | $46 | $52 | $44 |
| % Margin | 75.7% | 85.3% | 88.1% | 86.3% |
| EBITDA | -$1 | -$9 | $4 | $3 |
| % Margin | -1.4% | -17.5% | 6.9% | 5.2% |
| Net Income | -$20 | -$18 | -$4 | -$5 |
| % Margin | -24.9% | -33.5% | -7.4% | -10.5% |
| EPS Diluted | -0.79 | -2.59 | -0.66 | -1.04 |
| % Growth | 69.5% | -292.4% | 36.5% | – |
| Operating Cash Flow | -$14 | -$10 | -$3 | -$2 |
| Capital Expenditures | -$76 | -$0 | -$1 | -$1 |
| Free Cash Flow | -$90 | -$10 | -$4 | -$3 |